Kirkland & Ellis represented Court Square Capital Management, L.P. on the transaction, and Ropes & Gray advised Leonard Green & Partners, L.P. on the deal. Court...
Court Square Capital’s Closing of Single Asset Continuation Fund
Crown Laboratories’ $924 Million Merger with Revance Therapeutics
Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
Quantum’s Midstream Partnership with Comstock
Kirkland & Ellis counseled Quantum Capital Solutions on the transaction. Quantum Capital Solutions (“QCS”), an affiliate of Quantum Capital Group announced the formation of a midstream partnership...